Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Bupivacaine + Dexamethasone for Interscalene Block
NCT03969875Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Aug 2018
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Numerical Rating Score for Pain at 48 hours. Started Aug 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03969875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03969875.